Skip to content
lsd.com
Unknown statusPhase 4

Effects of Esketamine on Postpartum Depression

NCT05229913 · EEPD · Qinghai University

Closed to entry
Status
Not accepting participants
Phase 4
Phase
500
Target enrolment
—
Study sites

What it is testing

Summary

Different concentrations of Esketamine were used after cesarean section. Through the evaluation of postoperative psychological status and analgesic effect, the optimal dosage of Esketamine to exert the effects of depression and analgesia was analyzed.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Edinburgh Postpartum Depression Scale (EPDS) score

    Measured over The Edinburgh Postpartum Depression Scale (EPDS) score was performed day 42 after surgery

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

25 Years to 35 Years
Ages
FEMALE
Sex
Accepted
Healthy volunteers
Inclusion Criteria: 1. All participating patients signed an informed consent form; 2. Age 25-35 years old; 3. BMI≤35kg/m2; 4. ASA classification I or II; 5. Ultrasound showed a single pregnancy in the uterus Fetus, placental maturity grade Ⅱ+ Exclusion Criteria: 1. Unable or unwilling to sign the consent form, or unable to follow the research procedures; 2. History of thyroid disease; 3. A history of local anesthetic allergy; 4. A history of addiction or abuse to opioids and ketamine; 5. Preoperative mental illness; severe eclampsia; 6. Abnormal ECG, hypertension and severe heart Medical history 7. There are other contraindications to the use of esketamine

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT05229913 on ClinicalTrials.gov →

Last updated in the registry 2022-02-08. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits

Substance